Search Agents MCP CLI

Categories

AIStartupsVentureRobotics

Article Tags

CryptoSpaceEVsBiotechCloud ComputingHardwarePrivacySocial MediaTransportationFundraisingCommerceGovernmentMediaSemiconductorsWearablesDronesQuantum ComputingSaaSDevToolsDataAppsSecurityGadgetsFintechOpen Source

Story Topics

AIOpenAIAnthropicGoogleAppleNvidiaCryptoCybersecurityVenture CapitalRobotics
Entities
Swipe Feed Bookmarks Archive Leaderboard Stats RSS Sitemap
Contact Terms Privacy
Bloomberg · Rebecca Torrence ·

Warp Sciences, founded by former OpenAI CPO Kevin Weil to speed up drug development using AI, emerges from stealth with $215M at an $865M post-money valuation

Kevin Weil, the former OpenAI executive who led the ChatGPT maker's AI-for-science efforts, is launching a new startup aimed …

OpenAI AI Biotech Venture Capital
In this story Kevin Weil OpenAI Warp Sciences
Warp Sciences, founded by former OpenAI CPO Kevin Weil to speed up drug development using AI, emerges from stealth with $215M at an $865M post-money valuation

Lead Source

Bloomberg — Warp Sciences, founded by former OpenAI CPO Kevin Weil to speed up drug development using AI, emerges from stealth with $215M at an $865M post-money valuation ↗

How this story grew

Coverage · 0 Discussion · 0
Oct 22Oct 23

More

FinSMEs: FinSMEs
SiliconANGLE: SiliconANGLE
Pulse 2.0: Pulse 2.0
Lightspeed Venture Partners: Lightspeed Venture Partners
TechCrunch: TechCrunch

Discussion

Stu Smith JP Patil Rebecca Torrence
@warpsciences @lightspeedvp @guruchahal @rfradin @lightspeedvp @jrkelly @andrewcurran_ @lightspeedvp @amy @saranormous @peterjhebert @davidmarcus @manohar_paluri @sarthak__bhagat @katie_haun @snsf @smothers_john @ravi_lsvp @dyett @kayvz @shagunuppls @fidjissimo @kate_rouch @hesspresso_ @kevinweil @dpatil @sriramk @prashgarapati @thistrippjones @alokvasudev @dflieb @adambain @bobmcgrewai @claydumas @kevinweil

Related stories

Business Insider: Former OpenAI Chief Product Officer Kevin Weil is aiming to raise $150M for a new AI science startup, seeking a valuation of at least $750M
The Information: Wafer, which makes AI agents that optimize open-source models for a business's workload, raised a $40M Series A, a source says at a $200M+ valuation
Bloomberg: Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funds at a valuation of at least $40B
Axios: Pathos AI, which uses AI to develop oncology drugs, raised a $237M Series E at a $3B post-money valuation, up from $1.6B after its $365M Series D in May 2025
GamesBeat: Astromech, which uses genomic data to build predictive AI models of biological change, raised $20M at a $3.8B valuation, bringing its total funding to $60M

Discuss with AI

ChatGPT ↗ Claude ↗
← Back to TechSnif